In this regard, Rosmaninho-Salgadoa and colleagues demonstrated that DPP4 stimulates lipid accumulation and PPAR- expression through cleavage of NPY suggesting that sDPP4 might stimulate adipocyte differentiation ( in vitro
Obesity Medicine Association: Top Weight Loss Medications UCLA Health: Ozempic Face (and Other GLP-1 Side Effects) GLP-1 Agonists
Tirzepatide is following a similar trajectory
The vision loss MDL for Ozempic patients is new, so the filing requirements could change in the future
Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, including claims implying sameness with FDA-approved medications
High customer retention and consistent recurring revenue streams are key factors for sustainable growth